Back to Search Start Over

Anticoagulants oraux directs : dans quelles indications ? Lequel prescrire ? Pour ou contre chez les personnes fragiles et dans les situations atypiques ? Quelle surveillance et gestion des accidents hémorragiques ?

Authors :
Hoffmann, C.
Leven, C.
Le Mao, R.
De Moreuil, C.
Lacut, K.
Source :
Revue de Médecine Interne. Sep2020, Vol. 41 Issue 9, p598-606. 9p.
Publication Year :
2020

Abstract

Since their approval, the direct oral anticoagulants have been widely used in the management of venous thromboembolism, for stroke and systemic embolism prevention in non valvular atrial fibrillation, and in venous thromboembolism prophylaxis after surgical hip or knee replacement. Because they are easy to use, with oral fixed doses and no biological monitoring need, they are more and more prescribed. New indications are rising in cancer associated thrombosis in France beyond the 6 first months of treatment, and to prevent cardiovascular events after an acute coronary syndrome, or in stable coronary or peripheral arterial disease in Europe. The efficacity and safety of direct oral anticoagulants in frail patients or in unusual pathological contexts are not entirely known, but further data are coming and will probably bring new answers. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
02488663
Volume :
41
Issue :
9
Database :
Academic Search Index
Journal :
Revue de Médecine Interne
Publication Type :
Academic Journal
Accession number :
146038552
Full Text :
https://doi.org/10.1016/j.revmed.2020.05.026